Smarter Research
Annual Scientific Gathering
Our Annual Scientific Gathering convenes preeminent scientists and clinicians, as well as patients, brain tumor advocacy groups, industry leaders and government officials to advance innovations in brain cancer research and foster strategic collaboration.
September 29 - 30, 2011 - Sausalito, CA
Thursday, September 29
8:30 - 8:45 Welcome Remarks and Introductions
Max Wallace
CEO, Accelerate Brain Cancer Cure
8:45 - 9:30 Conversation with Phillipe Bishop, Vice President, Genentech
10:00 -10:30 Mechanisms of Resistance to Targeted Therapy
Web Cavanee
Director, Ludwig Institute for Cancer Research
10:30 -11:30 Therapeutic Potential of Targeting IDH1
Hai Yan
Assistant Professor of Pathology, Molecular, Duke University
Yu Xiong
William R. Kennen, Jr. Professor, UNC-Chapel Hill
11:30 - Noon Non-Stem Cell Origin for Oligodendroglioma
Bill Weiss
Professor, Dept. of Neurology, Pediatrics and Neurological Surgery, UCSF
Noon - 1:00 Lunch with talk by Chris O'Neill, Google
1:00 - 2:30 Immune Therapy Approaches
Charles Cobbs
California Pacific Medical Center
Duane Mitchell
Assistant Professor, Duke University
Amy Heimberger
Associate Professor, MD Anderson Cancer Center
2:45 - 3:45 Air Game
Development of Mebendazole and Approved Drugs to Treat Gliomas
Greg Riggins
Director, Division of Neurosurgery Research, Johns Hopkins University
Clinical Trial Update
Harry Gruber
CEO, Tocagen, Inc.
Update on Inhibition of Vasculogenesis Combined with Tumor Irradiation
Martin Brown
Professor, Stanford University
3:45 - 4:15 Time of Our Lives
Alex Harris
Founder, Center for Documentary Studies
Friday, September 30
8:30 – 9:00 The Case for Studying Chordoma
Josh Sommer
Executive Director, Chordoma Foundation
9:00 – 9:30 Chromosome 5p/9p/20q/8q Germline Alterations in Glioma
Bob Jenkins
Professor, Mayo Clinic
9:45 – 10:15 Identification and Development of Synergistic Combination Therapies for GBM
Jim Olson
Principal Investigator, Fred Hutchinson Cancer Research Center
10:15 – 10:30 Combination High Throughput Screening to Identify Novel Cancer Targets and Therapeutics
Ricky Rickles
Director, Zalicus
10:30 -11:00 Developments in Industry
Raj Chopra
Vice President, Translational Research, Celgene
11:00 - 11:30 Closing Remarks
Max Wallace
CEO, Accelerate Brain Cancer Cure
Links
Get Involved
Connect With Us
- Contact UsGet in touch with us
- FacebookMeet new friends and join the discussion in Facebook
- TwitterTweet and follow us. News, press & info
- RSS Feeds Subscribe to News